🇺🇸 FDA
Patent

US 11738053

Methods and compositions for treating chronic granulomatous disease

granted A61KA61K35/28A61K38/193

Quick answer

US patent 11738053 (Methods and compositions for treating chronic granulomatous disease) held by The Board of Regents of the University of Texas System expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
4
CPC classes
A61K, A61K35/28, A61K38/193